# The outbreak of the COVID-19 pandemic has led to a sudden shift in the dynamics of consumer behavior.

September 25, 2020

# Stress Management for Oncology Healthcare Professionals During COVID-19

Objective: To communicate simple tips of self-care and stress management with HCPs during COVID-19 pandemic.

Read now

September 25, 2020

# Stress Management for Oncology Healthcare Professionals During COVID-19

Objective: To communicate simple tips of self-care and stress management with HCPs during COVID-19 pandemic.

Read now

September 25, 2020

# Stress Management for Oncology Healthcare Professionals During COVID-19

Objective: To communicate simple tips of self-care and stress management with HCPs during COVID-19 pandemic.

Read now

#### Latest News

October 2, 2018 | 10.00 AM

##### Dr. Reddy's Laboratories announces the launch of AVIGAN® (Favipiravir) for COVID-19…

October 2, 2018 | 10.00 AM

##### Dr. Reddy's Laboratories announces the launch of AVIGAN® (Favipiravir) for COVID-19…

October 2, 2018 | 10.00 AM

##### Dr. Reddy's Laboratories announces the launch of AVIGAN® (Favipiravir) for COVID-19…

October 2, 2018 | 10.00 AM

##### Dr. Reddy's Laboratories announces the launch of AVIGAN® (Favipiravir) for COVID-19…

October 2, 2018 | 10.00 AM

##### Dr. Reddy's Laboratories announces the launch of AVIGAN® (Favipiravir) for COVID-19…

October 2, 2018 | 10.00 AM

##### Dr. Reddy's Laboratories announces the launch of AVIGAN® (Favipiravir) for COVID-19…

September 25, 2020

# Breast Cancer Management During COVID-19 Pandemic

September 25, 2020

# Managing Myelodysplastic Syndromes Patients During COVID-19 Pandemic

Objective: To communicate interim guidelines to safely manage myelodysplastic.

September 25, 2020

# Managing Myelodysplastic Syndromes Patients During COVID-19 Pandemic

Objective: To communicate interim guidelines to safely manage myelodysplastic.

September 25, 2020

# Managing Myelodysplastic Syndromes Patients During COVID-19 Pandemic

Objective: To communicate interim guidelines to safely manage myelodysplastic.

September 25, 2020

# Managing Myelodysplastic Syndromes Patients During COVID-19 Pandemic

Objective: To communicate interim guidelines to safely manage myelodysplastic.

September 25, 2020

# Managing Myelodysplastic Syndromes Patients During COVID-19 Pandemic

Objective: To communicate interim guidelines to safely manage myelodysplastic.

September 25, 2020

# Managing Myelodysplastic Syndromes Patients During COVID-19 Pandemic

Objective: To communicate interim guidelines to safely manage myelodysplastic.

September 25, 2020

# Breast Cancer Management of Prostate Cancer During COVID-19 Pandemic

September 25, 2020

# Managing Hematologic Malignancy Patient

Objective: To communicate interim guidelines to safely manage hematologic malignancies

September 25, 2020

# Managing Hematologic Malignancy Patient

Objective: To communicate interim guidelines to safely manage hematologic malignancies

September 25, 2020

# Managing Hematologic Malignancy Patient

Objective: To communicate interim guidelines to safely manage hematologic malignancies

September 25, 2020

# Prioritized and Safe Delivery of Systemic Anticancer Treatment During COVID-19

September 25, 2020

# Measures for provision of Optimal Oncology care During COVID-19

Objective: To communicate simple tips to HCP’s for delivering optimal care during COVID-19 pandemic.

September 25, 2020

# Cancer Care in Patients During COVID-19 Infection: use of hematopoietic growth factors

Objective: To communicate change in prophylaxis guidelines for cancer patients during COVID pandemic

September 25, 2020

# Breast Cancer Management of Prostate Cancer During COVID-19 Pandemic

September 25, 2020

# Managing Hematologic Malignancy Patient

Objective: To communicate interim guidelines to safely manage hematologic malignancies

September 25, 2020

# Managing Hematologic Malignancy Patient

Objective: To communicate interim guidelines to safely manage hematologic malignancies

September 25, 2020

# Managing Hematologic Malignancy Patient

Objective: To communicate interim guidelines to safely manage hematologic malignancies

September 25, 2020

# Prioritized and Safe Delivery of Systemic Anticancer Treatment During COVID-19

September 25, 2020

# Measures for provision of Optimal Oncology care During COVID-19

Objective: To communicate simple tips to HCP’s for delivering optimal care during COVID-19 pandemic.

September 25, 2020

# Cancer Care in Patients During COVID-19 Infection: use of hematopoietic growth factors

Objective: To communicate change in prophylaxis guidelines for cancer patients during COVID pandemic

##### Do you like this? Share with your friends!